Drug interactions with warfarin: what clinicians need to know.
作者信息
Juurlink David N
机构信息
Division of General Internal Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2007 Aug 14;177(4):369-71. doi: 10.1503/cmaj.070946.
Abstract
摘要
相似文献
1
Drug interactions with warfarin: what clinicians need to know.
CMAJ. 2007 Aug 14;177(4):369-71. doi: 10.1503/cmaj.070946.
2
Antiepileptic drugs and warfarin.
CMAJ. 2008 Jan 1;178(1):65; author reply 65. doi: 10.1503/cmaj.1070121.
3
Real risks of two common drugs.
Johns Hopkins Med Lett Health After 50. 1999 May;11(3):3.
4
[Adverse effects of cardiovascular agents].
Nihon Rinsho. 2007 Oct 28;65 Suppl 8:146-51.
5
Upper gastrointestinal mucosal abnormalities and blood loss complicating low-dose aspirin and antithrombotic therapy.
Aliment Pharmacol Ther. 2006 Feb 15;23(4):489-95. doi: 10.1111/j.1365-2036.2006.02784.x.
6
[Should warfarin and acetylsalicylic acid be withdrawn prior to tooth extraction?].
Tidsskr Nor Laegeforen. 2005 Sep 22;125(18):2498-9.
7
["Triple therapy" with warfarin, clopidogrel and acetylsalicylic acid. High risk treatment with unclear benefit].
Lakartidningen. 2007;104(48):3640-2.
8
[Acute coronary syndrome in patients using acetylsalicylic acid or warfarin].
Tidsskr Nor Laegeforen. 2004 Apr 22;124(8):1105-6.
9
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
CMAJ. 2007 Aug 14;177(4):347-51. doi: 10.1503/cmaj.070186.
引用本文的文献
1
Determining Drug Exposure Based on Medication Dispensing Data: A Validation Study of Vitamin K Antagonist Treatment Episodes Against INR Records.
Pharmacoepidemiol Drug Saf. 2025 Jun;34(6):e70158. doi: 10.1002/pds.70158.
2
A Case of Unexplained Warfarin Resistance: A Case Report and Literature Review.
J Tehran Heart Cent. 2023 Oct;18(4):302-306. doi: 10.18502/jthc.v18i4.14831.
3
Assessment of community pharmacists' knowledge about drug-drug interactions in Jeddah, Saudi Arabia.
Front Pharmacol. 2023 Jun 1;14:1209318. doi: 10.3389/fphar.2023.1209318. eCollection 2023.
4
Contemporary Antiplatelet and Anticoagulant Therapies for Secondary Stroke Prevention: A Narrative Review of Current Literature and Guidelines.
Curr Neurol Neurosci Rep. 2023 May;23(5):235-262. doi: 10.1007/s11910-023-01266-2. Epub 2023 Apr 11.
5
Local Tranexamic Acid for Preventing Hemorrhage in Anticoagulated Patients Undergoing Dental and Minor Oral Procedures: A Systematic Review and Meta-Analysis.
Healthcare (Basel). 2022 Dec 13;10(12):2523. doi: 10.3390/healthcare10122523.
6
Piperine Alters the Pharmacokinetics and Anticoagulation of Warfarin in Rats.
J Exp Pharmacol. 2020 Jun 19;12:169-179. doi: 10.2147/JEP.S257919. eCollection 2020.
7
Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients.
J Antimicrob Chemother. 2019 Oct 1;74(10):2848-2864. doi: 10.1093/jac/dkz221.
8
Management of anticoagulation in patients with metastatic castration-resistant prostate cancer receiving abiraterone + prednisone.
Support Care Cancer. 2019 Sep;27(9):3209-3217. doi: 10.1007/s00520-019-04816-y. Epub 2019 May 10.
9
The Effect of Demographic Factors and VKORC1 1639 G>A Genotypes on Estimated Warfarin Maintenance Dose in Iranian Patients Under Warfarin Therapy.
Indian J Hematol Blood Transfus. 2019 Jan;35(1):167-171. doi: 10.1007/s12288-018-0987-0. Epub 2018 Aug 1.
10
Association between genetic polymorphisms of CYP2C9 and VKORC1 and safety and efficacy of warfarin: Results of a 5 years audit.
Indian Heart J. 2018 Dec;70 Suppl 3(Suppl 3):S13-S19. doi: 10.1016/j.ihj.2018.02.005. Epub 2018 Mar 1.
本文引用的文献
1
Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding.
CMAJ. 2007 Aug 14;177(4):347-51. doi: 10.1503/cmaj.070186.
2
Nonsteroidal antiinflammatory drugs and the small intestine.
Curr Opin Gastroenterol. 2007 Mar;23(2):134-41. doi: 10.1097/MOG.0b013e328020045a.
3
Systematic overview of warfarin and its drug and food interactions.
Arch Intern Med. 2005 May 23;165(10):1095-106. doi: 10.1001/archinte.165.10.1095.
4
Interaction of warfarin with drugs, natural substances, and foods.
J Clin Pharmacol. 2005 Feb;45(2):127-32. doi: 10.1177/0091270004271404.
5
Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle.
Thromb Haemost. 2004 Oct;92(4):797-802. doi: 10.1160/TH04-02-0109.
6
Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions.
J Am Pharm Assoc (2003). 2004 Mar-Apr;44(2):142-51. doi: 10.1331/154434504773062591.
7
The influence of selective serotonin reuptake inhibitors on human platelet serotonin.
Thromb Haemost. 2004 Jan;91(1):119-28. doi: 10.1160/TH03-05-0330.
8
Pharmacogenetics of warfarin elimination and its clinical implications.
Clin Pharmacokinet. 2001;40(8):587-603. doi: 10.2165/00003088-200140080-00003.
9
Performance of community pharmacy drug interaction software.
J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):200-4. doi: 10.1016/s1086-5802(16)31230-x.
10
The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K.
Am J Gastroenterol. 1994 Jun;89(6):915-23.
Zotero 插件